about
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and ...
Read More
1.79
-0.06
(-3.24%)
187.7K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for OmniAb Inc is on 18 Mar 2026 for the purpose of OmniAb Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
OmniAb Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..